Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 4/20 | 0.42 |
| ▸ | PKM | P14618 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | ACACB | O00763 | 1/20 | 0.38 |
| ▸ | ACACA | Q13085 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27879631 | 0.80 | TAS1R3 (0.41) | ALDH1A1NPC1RAB9AKMT2AKDM4E | |
| SCHEMBL13753563 | 0.79 | ALDH1A1 (0.55) | ALDH1A1HTTNPC1RAB9AMAPT | |
| SCHEMBL28054630 | 0.78 | HSD17B10 (0.41) | LMNAHSD17B10 | |
| SCHEMBL27896422 | 0.73 | TDP1 (0.42) | ALDH1A1RAB9AMEN1KMT2AKDM4E | |
| SCHEMBL27879622 | 0.72 | GFER (0.45) | ALDH1A1RAB9AMEN1KMT2ALMNA | |
| SCHEMBL27896385 | 0.72 | TSHR (0.48) | ALDH1A1HTTMEN1KMT2ALMNA | |
| SCHEMBL27896409 | 0.72 | HTT (0.51) | ALDH1A1HTTMEN1KMT2ALMNA | |
| SCHEMBL28054724 | 0.71 | DPP4 (0.43) | KMT2A | |
| SCHEMBL27879636 | 0.70 | CHRM2 (0.37) | — | |
| SCHEMBL27879665 | 0.69 | CHRNA7 (0.51) | ALDH1A1NPC1RAB9APKMKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102791693-B | Hepatitis c virus inhibitors | BRISTOL-MYERS SQUIBB CO. (US) | 2016-04-13 | — | — | CN | claimed |
| CN-102791693-A | Hepatitis c virus inhibitors | BRISTOL MYERS SQUIBB CO | 2012-11-21 | — | — | CN | claimed |